Concepedia

Publication | Open Access

Cost-effectiveness of rivaroxaban in the prevention of venous thromboembolism: A Canadian analysis using the Ontario Ministry of Health Perspective

DOIFull Paper Access

21

Citations

28

References

2012

Year

Heather McDonald, A Diamantopoulos, Philip Wells, Michael Lees, Kerstin Folkerts, Fiona Forster, Jaithri Ananthapavan
Journal of Medical Economics

Abstract

This economic analysis suggests that the use of rivaroxaban for the prophylaxis of VTE after THR or TKR in Canada was cost-effective.

References

YearCitations

Page 1